NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

GSP Crop Science Lists Shares at a Premium

On Tuesday, GSP Crop Science's shares were listed on the exchanges at a premium, following a 1.61 times subscription to its issue between March 16-18 in the primary market.

Key Listing Details:

  • Listed on the National Stock Exchange (NSE) at Rs 328 per share, a premium of 2.5% compared to the issue price band of Rs 304-320 per share.
  • Listed on the BSE at Rs 332.30, up 3.84%.
  • Market capitalization post listing stood at Rs 1,545.82 crore.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

The company's market debut was better than the expectations in the grey market, which had anticipated a muted listing. GSP Crop Science, an Ahmedabad-based research-focused agrochemical company, had garnered Rs 120 crore from anchor investors before the fresh issue.

Issue Details:

  • The Rs 400-crore issue will be used for debt payment and general corporate purposes, with a portion totalling Rs 170 crore allocated for fresh issue proceeds.

With over 39 years of expertise in developing and manufacturing insecticides, herbicides, fungicides, and plant growth regulators in India, GSP Crop Science is a leading player in the agrochemical industry.

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

Investor Takeaway

Investors should note that GSP Crop Science's strong market debut may indicate a positive outlook for the company.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.